APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Gyrase Subunit B (EC 5.99.1.3)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchDNA Gyrase Subunit B (EC 5.99.1.3) Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Gyrase Subunit B (EC 5.99.1.3) Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal DNA Gyrase Subunit B (EC 5.99.1.3) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Gyrase Subunit B (EC 5.99.1.3) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Gyrase Subunit B (EC 5.99.1.3) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global DNA Gyrase Subunit B (EC 5.99.1.3) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for DNA Gyrase Subunit B (EC 5.99.1.3) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA Gyrase Subunit B (EC 5.99.1.3) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DNA Gyrase Subunit B (EC 5.99.1.3) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA Gyrase Subunit B (EC 5.99.1.3) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of DNA Gyrase Subunit B (EC 5.99.1.3) include Merck & Co., Inc., AstraZeneca Plc, Daiichi Sankyo Company Ltd and Abgentis Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for DNA Gyrase Subunit B (EC 5.99.1.3), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA Gyrase Subunit B (EC 5.99.1.3), also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Gyrase Subunit B (EC 5.99.1.3), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Gyrase Subunit B (EC 5.99.1.3) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Gyrase Subunit B (EC 5.99.1.3) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Gyrase Subunit B (EC 5.99.1.3) revenue, projected growth trends, production technology, application and end-user industry.

DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Company

Merck & Co., Inc.

AstraZeneca Plc

Daiichi Sankyo Company Ltd

Abgentis Limited

DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Type

VXC-100

VT-12008911

GYR-12

DS-2969

Others

DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Application

Bacterial Infections

Clostridium Diffclie Infections

Klebsiella Pneumoniae Infections

Others

DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Gyrase Subunit B (EC 5.99.1.3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Gyrase Subunit B (EC 5.99.1.3) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Gyrase Subunit B (EC 5.99.1.3).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of DNA Gyrase Subunit B (EC 5.99.1.3) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of DNA Gyrase Subunit B (EC 5.99.1.3) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Gyrase Subunit B (EC 5.99.1.3) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. VXC-100 Major Player Table 3. VT-12008911 Major Player Table 4. GYR-12 Major Player Table 5. DS-2969 Major Player Table 6. Others Major Player Table 7. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Bacterial Infections Major Player Table 9. Clostridium Diffclie Infections Major Player Table 10. Klebsiella Pneumoniae Infections Major Player Table 11. Others Major Player Table 12. DNA Gyrase Subunit B (EC 5.99.1.3) Industry Trends Table 13. DNA Gyrase Subunit B (EC 5.99.1.3) Industry Drivers Table 14. DNA Gyrase Subunit B (EC 5.99.1.3) Industry Opportunities and Challenges Table 15. DNA Gyrase Subunit B (EC 5.99.1.3) Industry Restraints Table 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2021-2026) & (US$ Million) Table 18. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2021-2026) Table 19. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2027-2032) & (US$ Million) Table 20. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2027-2032) Table 21. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Players (US$ Million) & (2021-2026) Table 22. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Players (2021-2026) Table 23. Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Headquarters & Area Served Table 25. Global DNA Gyrase Subunit B (EC 5.99.1.3) Players, Product Type & Application Table 26. Global DNA Gyrase Subunit B (EC 5.99.1.3) Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global DNA Gyrase Subunit B (EC 5.99.1.3) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 31. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 32. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2021-2026) Table 33. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2027-2032) Table 34. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 36. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 37. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2021-2026) Table 38. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2027-2032) Table 39. Merck & Co., Inc. Company Information Table 40. Merck & Co., Inc. Business Overview Table 41. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio Table 43. Merck & Co., Inc. Recent Development Table 44. AstraZeneca Plc Company Information Table 45. AstraZeneca Plc Business Overview Table 46. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio Table 48. AstraZeneca Plc Recent Development Table 49. Daiichi Sankyo Company Ltd Company Information Table 50. Daiichi Sankyo Company Ltd Business Overview Table 51. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio Table 53. Daiichi Sankyo Company Ltd Recent Development Table 54. Abgentis Limited Company Information Table 55. Abgentis Limited Business Overview Table 56. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio Table 58. Abgentis Limited Recent Development Table 59. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 60. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 61. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 62. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 63. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026) & (US$ Million) Table 65. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (US$ Million) & (2027-2032) Table 66. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 67. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 68. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 69. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 70. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026) & (US$ Million) Table 72. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (US$ Million) & (2027-2032) Table 73. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 74. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 75. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 76. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 77. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 78. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 79. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 80. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (US$ Million) & (2021-2026) Table 83. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Region (US$ Million) & (2027-2032) Table 84. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026) & (US$ Million) Table 85. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032) & (US$ Million) Table 86. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026) & (US$ Million) Table 87. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032) & (US$ Million) Table 88. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026) & (US$ Million) Table 90. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (US$ Million) & (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. DNA Gyrase Subunit B (EC 5.99.1.3) Image Figure 2. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Share 2021 VS 2025 VS 2032 Figure 4. VXC-100 Image Figure 5. VT-12008911 Image Figure 6. GYR-12 Image Figure 7. DS-2969 Image Figure 8. Others Image Figure 9. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Bacterial Infections Image Figure 12. Clostridium Diffclie Infections Image Figure 13. Klebsiella Pneumoniae Infections Image Figure 14. Others Image Figure 15. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (US$ Million) & (2021-2032) Figure 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global DNA Gyrase Subunit B (EC 5.99.1.3) Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2021-2032) Figure 23. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2021-2032) Figure 26. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032) Figure 28. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032) Figure 29. North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Country (2021-2032) Figure 30. United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032) Figure 35. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032) Figure 36. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Country (2021-2032) Figure 37. Germany DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032) Figure 47. China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032) Figure 48. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032) Figure 50. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032) Figure 51. Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Region (2021-2032) Figure 52. Japan DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032) Figure 60. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032) Figure 61. SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Country (2021-2032) Figure 62. Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt DNA Gyrase Subunit B (EC 5.99.1.3) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • VXC-100
  • VT-12008911
  • GYR-12
  • DS-2969
  • Others
Applications
  • Bacterial Infections
  • Clostridium Diffclie Infections
  • Klebsiella Pneumoniae Infections
  • Others
Companies covered
  • Merck & Co., Inc.
  • AstraZeneca Plc
  • Daiichi Sankyo Company Ltd
  • Abgentis Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Type
  3. 1.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 VXC-100
  5. 1.2.3 VT-12008911
  6. 1.2.4 GYR-12
  7. 1.2.5 DS-2969
  8. 1.2.6 Others
  9. 1.3 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application
  10. 1.3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Bacterial Infections
  12. 1.3.3 Clostridium Diffclie Infections
  13. 1.3.4 Klebsiella Pneumoniae Infections
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Dynamics
  1. 2.1 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Trends
  2. 2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Drivers
  3. 2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Opportunities and Challenges
  4. 2.4 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Perspective (2021-2032)
  2. 3.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Growth Trends by Region
  3. 3.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2021-2026)
  5. 3.2.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Players
  2. 4.1.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Players (2021-2026)
  3. 4.1.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Headquarters & Area Served
  7. 4.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Players, Product Type & Application
  8. 4.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market CR5 and HHI
  11. 4.6.3 2025 DNA Gyrase Subunit B (EC 5.99.1.3) Tier 1, Tier 2, and Tier 3
5 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
  1. 5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 5.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2021-2032)
6 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
  1. 6.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  3. 6.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck & Co., Inc.
  2. 7.1.1 Merck & Co., Inc. Company Information
  3. 7.1.2 Merck & Co., Inc. Business Overview
  4. 7.1.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
  6. 7.1.5 Merck & Co., Inc. Recent Developments
  7. 7.2 AstraZeneca Plc
  8. 7.2.1 AstraZeneca Plc Company Information
  9. 7.2.2 AstraZeneca Plc Business Overview
  10. 7.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
  12. 7.2.5 AstraZeneca Plc Recent Developments
  13. 7.3 Daiichi Sankyo Company Ltd
  14. 7.3.1 Daiichi Sankyo Company Ltd Company Information
  15. 7.3.2 Daiichi Sankyo Company Ltd Business Overview
  16. 7.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
  18. 7.3.5 Daiichi Sankyo Company Ltd Recent Developments
  19. 7.4 Abgentis Limited
  20. 7.4.1 Abgentis Limited Company Information
  21. 7.4.2 Abgentis Limited Business Overview
  22. 7.4.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
  24. 7.4.5 Abgentis Limited Recent Developments
8 North America
  1. 8.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2032)
  2. 8.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 8.2.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026)
  4. 8.2.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032)
  5. 8.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032)
  6. 8.4 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  7. 8.4.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026)
  8. 8.4.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032)
  9. 8.5 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032)
  10. 8.6 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country
  11. 8.6.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026)
  13. 8.6.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2032)
  2. 9.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 9.2.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026)
  4. 9.2.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032)
  5. 9.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032)
  6. 9.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  7. 9.4.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026)
  8. 9.4.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032)
  9. 9.5 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032)
  10. 9.6 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country
  11. 9.6.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026)
  13. 9.6.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2032)
  2. 10.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 10.2.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026)
  4. 10.2.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032)
  5. 10.3 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032)
  6. 10.4 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  7. 10.4.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026)
  8. 10.4.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032)
  9. 10.5 China DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2032)
  2. 11.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 11.2.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026)
  4. 11.2.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032)
  5. 11.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032)
  6. 11.4 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  7. 11.4.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026)
  8. 11.4.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032)
  9. 11.5 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032)
  10. 11.6 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country
  11. 11.6.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026)
  13. 11.6.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2032)
  2. 12.2 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Type (2027-2032)
  5. 12.3 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Application (2027-2032)
  9. 12.5 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country
  11. 12.6.1 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst